Printer Friendly

Siemens announces US FDA clearance for its Biograph mMR.

M2 EQUITYBITES-June 13, 2011-Siemens announces US FDA clearance for its Biograph mMR(C)2011 M2 COMMUNICATIONS http://www.m2.com

Supplier of technology to the healthcare industry Siemens Healthcare, a business division of Siemens AG (Frankfurt: SIE) (NYSE:SI), announced on Friday that the US Food and Drug Administration (FDA) has recently granted 510(k) clearance for its Biograph mMR.

The company said that its Biograph mMR is the first system worldwide to enable simultaneous whole-body acquisition of data from magnetic resonance (MR) and positron emission tomography (PET).

The Biograph mMR enables users to generate the location, function and metabolic activity of organs in a single image at the same time. It is designed to provide a more complete diagnostic picture.

Potential clinical applications for molecular MR include the early identification and staging of malignancies, therapy planning and treatment. The Biograph mMR shows the greatest promise in oncologic and neurologic applications where MR and PET have proven their clinical value, Siemens said.

Initial Biograph mMR installations are at the University Hospital in Tuebingen and the University Hospital 'Klinikum rechts der Isar' of the Munich Technical University, both in Germany, and Boston's Massachusetts General Hospital.

((Comments on this story may be sent to info@m2.com)).END.PUB430>PDJune 13, 2011>JNM2 EQUITYBITES.PRICEDATENOT APPLICABLE.DAY

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jun 13, 2011
Words:215
Previous Article:-Medivir not to prolong again takeover offer for Biophausia.
Next Article:Verizona[euro](tm)s request to end printed white paper listing delivery accepted by California PUC.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters